NCP Flanders
choose your programme
Horizon Europe

Horizon Europe is the main Research and Innovation Funding Programme of the European Commission.

Horizon 2020

Horizon 2020 is the previous Funding Programme. There are no longer calls, but projects can run until 2024.

Digital Europe

Digital Europe is a Funding Programme focused on bringing digital technology to businesses, citizens and administrations.

Other EU Funding

There are many other relevant EU funding programmes, managed by several agencies and directorates.

Partner search

There exist several tools and organisations that can help you to find the right partners for your Horizon Europe or Digital Europe project.

NCP Flanders Partner Search Service & Your NCP

NCP Flanders provides an overview of partner search requests received from stakeholders abroad. You can access this service here. The partner searches listed on this page have not been widely published and should not be further spread. These partner search requests are published as received, NCP Flanders does not vouch for the quality of these requests.

NCP Flanders has for each domain in Horizon Europe and for Digital Europe a dedicated advisor that is familiar with the ecosystem. If you are a stakeholder based in Flanders and would like to launch a partner search request please contact the NCP advisor responsible for your domain.

Funding & Tenders Portal

Also the Funding and Tenders portal has a partner search section. This is rather closely connected to the different call topics, and the list is often more crowded with consultants than opportunity seekers. But you surely can find some potential cooperation gems...

You can as well launch a search through the results platform of the F&T portal. It is not clear at the moment how connected both services are, so it's not a bad idea to check both!

 

 

Testimonial

image of Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.